Artificial Pancreas Device System Market Research Report by Type (CTR, CTT), End-user (Hospitals, Medical Centers, and Others), and Region (North America, Europe, APAC, RoW)- Forecast to 2027
Global Artificial Pancreas Device System Market–Overview
The requirement for safe and effective devices is the main factor impelling the demand for artificial pancreas device systems. Market reports connected with the healthcare industry have been made available by Market Research Future which generates reports on other business verticals that outlines the current market scenarios. The market is projected to attain USD 341.08 million while progressing at a 21.10% CAGR in the period of the forecast.
Furthermore, recent years have witnessed a surge in the number of FDA approvals for artificial pancreas device systems. The FDA is collaborating with medical device manufacturers, academic institutions, and diabetes care providers to foster innovation and expedite further development of the technology which is expected to boost the market growth over the forecast period. The global artificial pancreas device system market is expected to reach USD 341.08 Mn by the end of the forecast period.
Segmentation:
The global artificial pancreas device market has been segmented based on type and end user.
By type, the global artificial pancreas device market has been segmented into CTT (Control To Target) Systems and CTR (Control to Range) Systems
By end user, the global artificial pancreas device market has been segmented into hospitals and medical centers.
Competitive Landscape:
The notable players in the global Artificial Pancreas Device System Market include Johnson & Johnson, Tandem Diabetes Care Inc., Medtronic Plc, Inreda Diabetic B.V., Insulet Corp, Beta Bionics, Dexcom Inc., F. Hoffmann-La Roche Ltd., Bigfoot Biomedical, TypeZero Technologies LLC,
Cellnovo, and Pancreum Inc.
Regional Analysis:
By region, the global artificial pancreas device system market has been segmented into the Americas, Asia Pacific, Europe, and the Middle East & Africa (MEA).
The Americas, North America in particular, is leading the global artificial pancreas device system market. Robust healthcare infrastructure and high healthcare expenditure and fast uptake of the latest technologies in the region can be credited for the growth of the market.
Europe too is a significant market for artificial pancreas. Government funding for R&D, high healthcare expenditure and the presence of sophisticated healthcare infrastructure support market growth.
APAC is slated to showcase rapid growth over the forecast period due to high healthcare expenditure in the emerging economies such as China and India. The MEA market is expected to showcase limited growth owing to weak economic conditions and low healthcare penetration.
Get Full Report at https://www.marketresearchfuture.com/reports/artificial-pancreas-device-system-market-6671
RELATED REPORTS
Global Invisible Orthodontics Market Research Report—Forecast till 2025
Global Pain Patch Market Research Report—Forecast till 2025
Body Composition Analyzers Market Research Report - Global Forecast till 2025
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
コメント